商务合作
动脉网APP
可切换为仅中文
Shanghai, China, 20 March 2025 —— MicroPort
中国上海,2025年3月20日 —— 微创
®
®
MedBot™ is proud to announce that its Toumai
MedBot™ 很自豪地宣布其 Toumai
®
®
SP Laparoscopic Surgical Robot has received market approval from the National Medical Products Administration (NMPA) (registration no. 20253010347) in China. This groundbreaking surgical robot is approved for clinical use across a variety of departments, including urology, general surgery, and gynecology..
SP腹腔镜手术机器人已获得中国国家药品监督管理局(NMPA)的市场批准(注册号:20253010347)。这款开创性的手术机器人已获批在泌尿科、普通外科和妇科等多个科室进行临床使用。
The Toumai
托迈(Toumai)
®
®
SP boasts an innovative, highly integrated single-port design that enables a 2.5cm incision at the belly button, through which three snake-shaped instruments and a snake-shaped endoscope can be inserted. This compact approach excels in complex environments, such as narrow spaces and intricate anatomical structures..
SP拥有创新的、高度集成的单孔设计,可以在肚脐处开一个2.5厘米的小切口,通过该切口插入三条蛇形器械和一条蛇形内窥镜。这种紧凑的方法在狭窄空间和复杂解剖结构等复杂环境中表现出色。
With its small footprint, high adjustability, and minimal space requirements, the robot is ideal for operating rooms with limited space, improving adaptability in the surgical environment.
由于其体积小、可调节性高且空间需求小,该机器人非常适合在空间有限的手术室中使用,提高了手术环境中的适应性。
Other key features of Toumai
图迈的其他关键特征
®
®
SP include:
SP 包含:
Multi-degree-of-freedom Snake-shaped Instruments: Toumai
多自由度蛇形器械:Toumai
®
®
SP features a 3D high-definition flexible electronic endoscope designed with a multi-degree-of-freedom snake-shaped structure. This design provides a wide field of view and eliminates blind spots. With high-quality imaging, low latency, dual-lens synchronous focusing, and personalized pupil distance calibration, it ensures stable images and smooth operation.
SP 特点是一款采用多自由度蛇形结构设计的3D高清柔性电子内窥镜。该设计提供了广阔的视野,消除了盲区。凭借高质量成像、低延迟、双镜头同步对焦以及个性化瞳距校准,确保了图像稳定和操作流畅。
The endoscope also offers multiple control modes, an extended lifespan, and helps reduce surgical costs..
该内窥镜还提供多种控制模式,延长了使用寿命,并有助于降低手术成本。
Crossed Dual C-arm:
交叉双C臂:
Toumai
图迈
®
®
SP adopts crossed dual C-arm technology, enabling a safer fixed-point design. This allows surgeon to precisely control dual robotic arms through a single minimally invasive incision, supporting full abdominal and pelvic surgeries with enhanced flexibility. By eliminating the need for patient repositioning, it helps reduce the risk of tissue damage..
SP采用交叉双C臂技术,实现更安全的定点设计。该设计允许外科医生通过单一的微创切口精确控制双机械臂,支持全腹部和盆腔手术,灵活性更高。通过消除患者体位调整的需要,有助于降低组织损伤的风险。
This approval marks the launch of MicroPort
该批准标志着微创医疗的上市
®
®
MedBot™’s fifth surgical robot, further expanding its portfolio of innovative robotic solutions across various specialties and surgical approaches.
MedBot™的第五台手术机器人,进一步扩展了其在各个专业和手术方法上的创新机器人解决方案组合。
About MicroPort
关于微创
®
®
MedBot™
MedBot™
Commenced its development for laparoscopic surgery robots in 2014, and officially established in Shanghai in 2015, Shanghai MicroPort MedBot (Group) Co., Ltd. ('MicroPort
2014年开始进行腹腔镜手术机器人的研发,并于2015年正式在上海成立的上海微创医疗机器人(集团)股份有限公司(“微创®
®
®
MedBot™', stock code: 02252.HK), a subsidiary of MicroPort Scientific Corporation ('MicroPort
MedBot™,股票代码:02252.HK),是微创医疗科学有限公司(“微创医疗”)的子公司
®
®
', stock code: 00853.HK), is currently the only surgical robot company in the world with businesses covering five promising subsectors of surgical robots, including endoscopy, orthopedics, vascular intervention, natural orifice surgery, and percutaneous puncture. At MicroPort
“,股票代码:00853.HK)是目前全球唯一一家业务覆盖腔镜、骨科、血管介入、自然腔道、经皮穿刺五大手术机器人黄金赛道的手术机器人公司。在微创®机器人集团”
®
®
MedBot™, we are committed to meeting the growing demand for cutting-edge robotic surgery. By integrating advanced research on robotics, control algorithms, image-based navigation, and precision imaging, we provide comprehensive intelligent surgical solutions to prolong and reshape the lives of patients, lead the advancement of robotic surgery, and shape the era of intelligent surgery..
MedBot™致力于满足对尖端机器人手术日益增长的需求。通过整合机器人技术、控制算法、基于图像的导航和精准成像等先进研究,我们提供全面的智能手术解决方案,延长并重塑患者生命,引领机器人手术的进步,开创智能手术的新时代。
More information is available at: www.medbotsurgical.com/en
更多信息请访问:www.medbotsurgical.com/en